CHI3L1 and androgen insensitivity syndrome: Moreover, it is known that SAP is a standout complication after AIS and leads to poor clinical outcomes [11], nevertheless, there is limited data evaluating the prognostic role of YKL-40 in clinical outcomes with SAP in AIS patients.